title: A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis.
abstract: We studied the incidence of leukemia cutis (LC) in 381 consecutive patients with acute myeloid leukemia (AML) in a single institution and compared the demographic, hematological, and cytogenetic findings in AML patients with and without LC. We also examined the response to intensive chemotherapy, overall survival, and duration of remission in this patient population with regard to the presence of LC. The prevalence of LC was 3.7% in clinically diagnosed patients and 2.9% in biopsy-proven cases, respectively. Patients with and without LC did not differ with regard to age, sex, white blood cell counts, hemoglobin, fibrinogen, and platelet counts at diagnosis, but lactate dehydrogenase (LDH) was significantly higher in patients with LC. Various karyotype abnormalities were found, but in patients with LC numerical abnormalities of chromosome 8 were significantly more common ( P<0.0001). Patients with LC did not differ from patients without LC with regard to remission rate, but there was a trend towards shorter remission duration in patients with LC. We conclude that patients with LC have some features different from patients without this symptom. The increased frequency of numerical aberrations of chromosome 8 in patients with LC was the most interesting observation of our study. The pathophysiological significance of this finding remains to be determined.
authors.affiliation: Department of Internal Medicine I, Division of Hematology and Hemostaseology, General Hospital Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria. hermine.agis@akh-wien.ac.at
authors.forename: H
authors.initials: H
authors.lastname: Agis
authors.forename: A
authors.initials: A
authors.lastname: Weltermann
authors.forename: C
authors.initials: C
authors.lastname: Fonatsch
authors.forename: O
authors.initials: O
authors.lastname: Haas
authors.forename: G
authors.initials: G
authors.lastname: Mitterbauer
authors.forename: L
authors.initials: L
authors.lastname: Müllauer
authors.forename: S
authors.initials: S
authors.lastname: Schreiber
authors.forename: I
authors.initials: I
authors.lastname: Schwarzinger
authors.forename: W
authors.initials: W
authors.lastname: Juretzka
authors.forename: P
authors.initials: P
authors.lastname: Valent
authors.forename: U
authors.initials: U
authors.lastname: Jäger
authors.forename: K
authors.initials: K
authors.lastname: Lechner
authors.forename: K
authors.initials: K
authors.lastname: Geissler
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002869:Chromosome Aberrations; D002898:Chromosomes, Human, Pair 8; D005260:Female; D006801:Humans; D015994:Incidence; D007938:Leukemia / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D012737:Sex Factors; D016019:Survival Analysis